Bruker Corporation (BRKR) vs Vaxcyte, Inc. (PCVX)

A side-by-side comparison of Bruker Corporation and Vaxcyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BRKR vs PCVX

growth of $100 · dividends reinvested · last 6y
BRKR +55.4% (+7.6%/yr)PCVX +182.3% (+18.9%/yr)PCVX compounded faster over this window
100200300400Start $100202120222023202420252026$155$282
BRKR PCVX

BRKR vs PCVX: by the numbers

  • •PCVX is the larger company ($9.40B vs $9.22B market cap).
  • •Both run net losses; PCVX's is the smaller (0.00% vs -2.03% net margin).
  • •BRKR pays a dividend (0.23% yield), while PCVX has no payments in the available dividend history.

Metrics side by side

Valuation

MetricBRKRPCVX
Forward P/E28.54N/A
P/S ratio2.63N/A
P/B ratio3.843.41
EV / EBITDA30.70N/A
FCF yield1.02%N/A

Profitability

MetricBRKRPCVX
Gross margin46.69%0.00%
Operating margin3.61%0.00%
Net margin-2.03%0.00%
ROE-2.97%-38.59%
ROIC2.56%-40.65%

Dividends

MetricBRKRPCVX
Dividend yield0.23%N/A

Growth (annualized)

MetricBRKRPCVX
Revenue CAGR (5Y)9.10%N/A
FCF CAGR (5Y)-21.33%N/A
Total return CAGR (5Y)-3.42%25.08%

Frequently asked

Does BRKR or PCVX pay a bigger dividend?
BRKR pays a dividend (0.23% yield), while PCVX has no payments in the available dividend history.
How have BRKR and PCVX total returns compared?
Over the past 5 years, BRKR delivered -3.42% and PCVX delivered 25.08% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.